This page was printed from the South & West Devon Formulary and Referral site at

Please ensure you are using the current version of this document

nhs logo
South & West Devon Formulary and Referral
  • Homepage
  • Formulary
    • Chapters
    • Committee
    • Information
    • Updates
    • COVID-19 Updates
  • Referral
    • Key messages
    • Policies
    • Western locality
    • SDevon & Torbay
  • Refer-CV19 CRGs
    • CRG updates
    • Western CRGs
    • S. Devon & Torbay CRGs
    • CV-19 information
  • Learning

2. Cardiovascular

  • Management of atrial fibrillation
  • Drugs that prolong the QT interval
  • Anticoagulation prescribing guidance
  • Management of suspected deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Secondary prevention of stroke / TIA in primary care
  • Management of angina
  • Chronic heart failure guidance
  • Management of hypertension
  • Management of blood lipids
  • 2.1 Positive inotropic drugs
  • 2.2 Diuretics
  • 2.3 Anti-arrhythmic drugs
  • 2.4 Beta-adrenoceptor blocking drugs
  • 2.5 Hypertension and heart failure
  • 2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
  • 2.7 Sympathomimetics
  • 2.8 Anticoagulants and protamine
  • 2.9 Antiplatelet drugs
  • 2.10 Stable angina, acute coronary syndromes, and fibrinolysis
  • 2.11 Antifibrinolytic drugs and haemostatice
  • 2.12 Lipid regulating drugs
  • 2.13 Local sclerosants

2. Cardiovascular

  • Management of atrial fibrillation
  • Drugs that prolong the QT interval
  • Anticoagulation prescribing guidance
  • Management of suspected deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Secondary prevention of stroke / TIA in primary care
  • Management of angina
  • Chronic heart failure guidance
  • Management of hypertension
  • Management of blood lipids
  • 2.1 Positive inotropic drugs
  • 2.2 Diuretics
  • 2.3 Anti-arrhythmic drugs
  • 2.4 Beta-adrenoceptor blocking drugs
  • 2.5 Hypertension and heart failure
  • 2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
  • 2.7 Sympathomimetics
  • 2.8 Anticoagulants and protamine
  • 2.9 Antiplatelet drugs
  • 2.10 Stable angina, acute coronary syndromes, and fibrinolysis
  • 2.11 Antifibrinolytic drugs and haemostatice
  • 2.12 Lipid regulating drugs
  • 2.13 Local sclerosants

Referral guidelines - Cardiology (Western Locality)

 

Home > Formulary > Chapters > 2. Cardiovascular

 

  • First line
  • Second line
  • Specialist
  • Hospital
  • Learning
  • Refer-CV19 CRGs
  • Referral
  • Formulary
Apple App Store Google Play Store
Return to Devon-wide Homepage | Apple App Store | Google Play Store
Accessibility | App | Contact Formulary | Cookies & Privacy | Referral feedback
Website designed & developed by the CEMO Team, NEW Devon CCG, built by Reactor15